Anavex Life Sciences
AVXL
AVXL
67 hedge funds and large institutions have $36.1M invested in Anavex Life Sciences in 2019 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 24 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
15% less capital invested
Capital invested by funds: $42.6M → $36.1M (-$6.56M)
82% less call options, than puts
Call options by funds: $344K | Put options by funds: $1.87M
Holders
67
Holding in Top 10
–
Calls
$344K
Puts
$1.87M
Top Buyers
| 1 | +$311K | |
| 2 | +$236K | |
| 3 | +$211K | |
| 4 |
D.E. Shaw & Co
New York
|
+$185K |
| 5 |
Morgan Stanley
New York
|
+$119K |
Top Sellers
| 1 | -$291K | |
| 2 | -$101K | |
| 3 | -$63K | |
| 4 |
VF
Virtu Financial
New York
|
-$42.8K |
| 5 |
Squarepoint
New York
|
-$40K |